Filing Details

Accession Number:
0001144204-10-024396
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-05-04 13:00:00
Reporting Period:
2009-08-11
Filing Date:
2010-05-04
Accepted Time:
2010-05-04 20:51:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1060736 Seattle Genetics Inc SGEN Biological Products, (No Disgnostic Substances) (2836) 911874389
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1087939 Julian Baker 667 Madison Avenue, 17Th Floor
New York NY US 10021
Yes No Yes No
1087940 Felix Baker 667 Madison Avenue, 17Th Floor
New York NY US 10021
Yes No Yes No
1244390 Baker Bros. Capital (Gp), Llc 667 Madison Avenue 17Th Floor
New York NY US 10021
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2009-08-11 798 $10.75 481,890 No 4 P Indirect Through Partnership
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect Through Partnership
Footnotes
  1. In addition to Baker Bros. Capital (GP), LLC, this Form 4 is being filed jointly by Felix J. Baker and Julian C. Baker, each of whom has the same business address as Baker Bros. Capital (GP), LLC and may be deemed to have a pecuniary interest in securities owned by it. Felix J. Baker is a director of the Issuer. Because of certain relationships with other security holders of the Issuer, the Reporting Persons are filing solely for informational purposes as if they were members of a group with such security holders. (Continued in footnote 2).
  2. However, the Reporting Persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of Section 13(d)(3) of the Securities Exchange Act of 1934, as amended, or Rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
  3. Represents shares of common stock acquired by Baker Bros. Investments II, L.P.
  4. Represents shares 233,020 shares owned directly by Baker Bros. Investments, L.P. and 248,870 shares owned directly by Baker Bros. Investments II, L.P., limited partnerships of which the sole general partner is Baker Bros. Capital, L.P., a limited partnership of which the sole general partner is Baker Bros. Capital (GP), LLC. Felix J. Baker and Julian C. Baker are controlling members of Baker Bros. Capital (GP), LLC.